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. Glide docking-based frequency with which fragments appeared in the three substitution positions on a tripeptoid backbone containing T2AA as a fragment. 
Figure S6.
Structures of the peptoid-based compounds containing T2AA as a fragment.
Figure S7.
Dose response curves for each of the compounds listed in Table 1 . Table S1 . List of each peptoid-based ligand that was synthesized for this study. The calculated mass of each compound is shown, along with its experimentally determined mass by high resolution electrospray ionization or MALDI-TOF mass spectrometry. The yield for the synthesis of each ligand is also displayed.
Tables S2-S4. Descriptor statistics from the Bayesian classification method showing values for globularity, CW2, EDmin3 and IW4 for the full virtual set of tripeptoids, known inhibitors of protein-protein interactions or known non-inhibitors of protein-protein interactions, respectively.
Methods. Experimental procedures for the synthesis of non-commercially available primary amines and T2AA, as well as supporting experimental procedures for the synthesis and purification of His-tagged PCNA and FAM-PL peptide.
HPLC Traces. Figure S1 . Glide docking-based frequency with which fragments appeared in the three substitution positions on a tripeptoid backbone containing T2AA as a fragment. A set of 37 fragments, in addition to two forms of T2AA (see Figure 1 of main text), were virtually combinatorially incorporated into a tripeptoid backbone, and were screened against the crystal structure of PCNA-T3 (PDB ID: 3VKX) in silico using the Glide HTVS, SP and XP docking algorithms. The frequency that respective fragments appeared in positions R 1 , R 2 or R 3 were tallied for the top 50 hits. The percentage of the cumulative total of substitution frequency (out of a possible 50) at a given position is shown above columns. 
Figure S3
. T2AA FP binding curves at different concentrations of PCNA. Using the same amount of FAM-PL peptide, the dynamic range of the FP assay increased significantly as additional PCNA was added to the assay. As can be seen here, increasing the concentration of PCNA from 100 nM to 400 nM increased the dynamic range from approximately 15 mA to more than 40 mA. Increasing the concentration of PCNA even higher would then theoretically continue to enhance the dynamic range.
Figure S4
. PCNA titration for determining affinity of FAM-PL. Increasing amounts of recombinant PCNA were added to a fixed concentration of the FAM-PL peptide (5 nM) in binding buffer. The data were fit to Equation 2.3 was used to determine the K d value for the peptide (here, the calculated affinity was 107 nM) and the Hill slope of 1.745 =/-0.252.
Figure S6
. Structure of T2AA-conjugates. For second generation peptoid inhibitors of PCNA, T2AA was coupled to the N-terminus of peptoids or peptides anchored on solid phase resin to generate the molecules shown above.
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T2AA-NPip-NLys S10 Figure S7 . Dose response curves for all compounds listed in Table 1 of main text. Figure S12. MD simulation interaction diagrams. Interactions between PCNA amino acids and peptoid ligands or the PL peptide were monitored over the course of each MD simulation. The number of trajectory frames in which an interaction occurred was recorded and listed as a fraction of the total number of possible simulation frames. Numbers larger than 1.0 indicate that during the simulation, two or more simultaneous interactions between a given protein residue and the ligand were taking place. Figure S13 . Predicted PCNA surface electrostatic potential and specific molecular contacts between NLys-NPip-NBal and PCNA. (A) The average MD output structure of NLys-NPip-NBal is shown with the predicted vacuum electrostatic potential (ranges from red [negative] to blue [positive], with gray being neutral) of PCNA shown as a surface. (B) The positively charged primary amine of the inhibitor is predicted to form hydrogen bonding and electrostatic contacts with residues Gln125 and Glu124 of PCNA. (C) The benzyl alcohol fragment of NLys-NPip-NBal is predicted to bind in a shallow surface pocket defined by mostly hydrophobic contacts, while the hydroxyl group has the potential to interact with PCNA residues Ala252, Pro253 or Lys254 through hydrogen bonding or water bridging. Figure S14 . Enrichment plot for Bayesian model prediction of the 2P2I Hunter compound set. A leaveone-out cross-validation of the Bayesian model for the 1058-ligand 2P2I Hunter set was performed, an enrichment plot was generated, and the percentages of true category members captured at particular cutoff percentages were listed. From this, a best split value was calculated as -0.188 for the Bayesian score. 
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Synthesis of Non-Commercially Available Primary Amines and T2AA
Scheme 1 Synthesis of NArg Synthesis of N- ((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-yl) sulfonyl)-1H-pyrazole-1carboximidamide (1). 16.16 g (55.96 mmol) of 2,2,5,7,8-pentamethylchroman-6-sulfonyl chloride (Combi-Blocks, Inc., San Diego, CA) was dissolved in dioxane (200 mL), and 9.07 g (61.88 mmol) of 1H-pyrazole-1-carboxamidine HCl dissolved in dioxane (200 mL) was added to the solution followed by 22 mL (2 eq.) of DIEA. The reaction mixture was stirred at room temperature for 48 hours, at which time all of the 1H-pyrazole-1-carboxamidine HCl had been consumed as confirmed via TLC. The dioxane was evaporated in vacuo and the remaining brown oil was redissolved into 200 mL DCM. The organic layer was washed with water (3 x 200 mL), dried over sodium sulfate and evaporated to give a brown solid. The crude material was recrystallized three times from ethanol to give 13.17 g (64.9% yield) of 1 as a white solid. 1 H NMR (500 MHz, CDCl3) δ 8.21 (dd, J = 2.8, 0.7 Hz, 1H), 7.67 (dd, J = 1.6, 0.7 Hz, 1H), 6.40 (dd, J = 2.9, 1.6 Hz, 1H), 2.98 (s, 2H), 2.62 (s, 3H), 2.56 (s, 3H), 2.11 (s, 3H), 1.47 (s, 6H). 13 C NMR (126 MHz, CDCl3) δ 12. 34, 17.86, 19.16, 28.48, 42.99, 86.67, 109.47, 117.74, 124.83, 128.92, 130.88, 132.98, 139.13, 143.44, 148.66, 159.41 2, 4, 6, "NArg") . 5.88 g (17.5 mmol) of 1 was dissolved into DCM (100 mL) and was added dropwise to 6.75 g (91.1 mmol; 5.2 equiv.) of 1,3-diaminopropane dispersed in DCM (100 mL) at room temperature while stirring. The reaction was allowed to stir for 24 hours, at which time TLC showed that all of 1 had been consumed. The reaction mixture was washed with water (3 x 100 mL) and brine (100 mL), the organic layer was dried over sodium sulfate, and the organics were evaporated in vacuo to give an off-white solid. 71, 138.15, 132.32, 132.12, 124.62, 117.50, 109.22, 86.35, 43.10, 39.78, 37.98, 28.50, 19.23, 17.85, 12.39 of 1 M borane-THF in THF was added dropwise. The reaction mixture was heated to reflux for eight hours, and then allowed to cool to room temperature. 100 mL of MeOH was added to quench the remaining borane-THF, and the reaction was stirred for an additional 15 minutes. The reaction solution was then filtered over celite and evaporated in vacuo to give a light yellow solid. 250 mL of DCM was then added to the reaction flask containing the crude intermediate product, followed by 37 mL (2 equiv.) of triethylamine. The reaction was cooled to 0°C, 21 mL (1.1 equiv.) of trifluoroacetic anhydride was added dropwise and the reaction was allowed to stir overnight, allowing it to gradually reach room temperature. After 22 hours of reaction time, all of the starting material had been consumed as evidenced by TLC. 250 mL of water was added to the reaction and the organic layer was separated. The aqueous layer was extracted once more with 250 mL of DCM, the combined organics were washed with water (100 mL), and were dried over sodium sulfate, N-(4-(((tert-butyldimethylsilyl) oxy)methyl)benzyl)-2,2,2-trifluoroacetamide (4). 141.83, 134.51, 128.03, 126.72, 117.90, 64.65, 43.81, 26.04, 18.53, -5.17 Synthesis of (4-(((tert-butyldimethylsilyl)oxy)methyl)phenyl)methanamine (5; "NBal"). 20.8 g (59.9 mmol) of 4 was dissolved in methanol (100 mL), followed by the addition of a 2 M aqueous solution of potassium carbonate (27.1 g in 100 mL water). The reaction was heated to reflux for seven hours, and then allowed to cool to room temperature. Methanol was evaporated from the S31 reaction mixture in vacuo, the remaining aqueous solution was transferred to a separatory funnel, and was extracted with DCM (2 x 400 mL). The combined organics were washed with water (100 mL), dried over sodium sulfate, filtered and evaporated in vacuo to give a yellow oil. 85, 139.83, 126.87, 126.18, 64.70, 46.16, 29.35, 25.90, -5.29 
Synthesis
of N-(N-(3-aminopropyl)carbamimidoyl)-2,
Synthesis of
Scheme 3 Synthesis of NBza
Synthesis of 4-((2,2,2-trifluoroacetamido)methyl)benzoic acid (6). 21.16 g (140 mmol) of 4-(aminomethyl) benzoic acid was suspended in 450 mL of dichloromethane, followed by 42.0 mL (301 mmol) of triethylamine. The reaction was then cooled in an ice bath, and 60.44 g (2.06 eq.) of trifluoroacetic anhydride in 50 mL of dichloromethane was added dropwise over the course of 1 hour. The reaction was stirred for an additional three hours while being allowed to gradually warm to room temperature. 500 mL of aqueous saturated sodium bicarbonate solution was then slowly added to the reaction mixture in portions, and the solution was acidified with 4 N HCl (pH S32 < 3). The resultant precipitate was collected via filtration, and the filter cake was washed three times with water and twice with ice-cold ether. The solid was dissolved in ethyl acetate, dried over sodium sulfate, filtered, transferred to a round bottom flask and evaporated to give an off-white solid. The product was recrystallized from ethyl acetate/hexanes three times to give 24.63 g 97, 162.96, 145.92, 131.66, 130.49, 128.91, 127.95, 2, methyl)benzoate (7). 12.55 g (50.77 mmol) of 6 was dissolved in anhydrous THF (150 mL), and 135 mL of t-butanol and 6.20 g (50.75 mmol) DMAP were added. The reaction was cooled to 0°C under argon, and 29.2 g (152 mmol) of EDCI was added followed by an additional 50 mL of anhydrous THF to wash down the insides of the 80. 63, 116.22, 127.40, 129.31, 130.45, 142.54, 156.56, 164.70 57, 147.58, 130.47, 129.60, 126.71, 80.76, 46.02, 28.12 Synthesis of 2-((tert-butyldimethylsilyl)oxy)ethan-1-amine (9; "NEal"). 6.11 g (100 mmol) of ethanolamine and 13.62 g (2 equiv.) of imidazole were dissolved in DCM (100 mL) in a 500 mL round bottom flask. 15.83 g (105 mmol) of tert-butyldimethylchlorosilane dissolved in DCM (50 mL) was added dropwise over the course of 20 minutes, and the reaction mixture was stirred for one hour at room temperature. At that time, all of the starting material had been consumed as S34 confirmed by TLC; 100 mL of water was added and the layers were separated. The aqueous layer was extracted twice with DCM (2 x 100 mL), and the combined organics washed with water (50 mL), dried over sodium sulfate and evaporated to give 13.68 g (77.9% yield) of 9 as a clear oil. 1 H NMR (300 MHz, CDCl3) δ 3.57 (t, J = 5.36 Hz, 2H), 2.71 (t, J = 5.25 Hz, 2H), 2.08 (s, 2H, NH2), 0.84 (s, 9H), 0.00 (s, 6H). 13 C NMR (75 MHz, CDCl3) δ 65. 13, 44.27, 25.96, 18.35, -5.27 Synthesis of tert-butyl (4-aminobutyl)carbamate (10; "NLys"). 50.02 g (567.4 mmol) of 1,4diaminobutane was dissolved in chloroform (600 mL) and was cooled to 0°C. 13.17 g (6.03 mmol) of di-tert-butyl dicarbonate dissolved in chloroform (300 mL) was added drop-wise over the course of two hours and the reaction was stirred overnight, allowing it to reach room temperature. After 21 hours of reaction time, the entire reaction mixture was transferred to a separatory funnel and was washed with water (8 x 200 mL), dried over sodium sulfate and evaporated in vacuo to give 10.71 g (94.3% yield) of 10 as a clear oil. 1 H NMR (300 MHz, CDCl3) δ 4.84 (s, 1H), 3.04 (t, 2H), 2.64 (t, J = 6.7 Hz, 2H), 1.46 -1.38 (m, 4H), 1.37 (s, 9H). 13 C NMR (75 MHz, CDCl3) δ 155. 93, 78.82, 41.70, 40.30, 30.77, 28.32, 27.37 
S35
Scheme 4 Synthesis of NTrp
Synthesis of N-(2-(1H-indol-3-yl)ethyl)-2,2,2-trifluoroacetamide (11). 19.99 g (124.8 mmol) of tryptamine (AK Scientific, Inc., Union City, CA) was dissolved in DCM (300 mL) followed by the addition of 11.1 mL (1.1 equiv.) of pyridine. This solution was cooled to 0°C and 19.4 mL (1.1 equiv.) of trifluoroacetic anhydride was added dropwise. After 22 hours of reaction time, all of the starting material had been consumed, as evidenced by TLC; the reaction mixture was washed with 2 N HCl (3 x 250 mL), water (100 mL) and brine (100 mL), dried over sodium sulfate and evaporated to give a brown solid. This solid was dissolved in a mixture of acetone and DCM and was absorbed onto silica gel. This was dry loaded into an empty flash column, and the product was -butyl 3-(2-(2,2,2-trifluoroacetamido) ethyl)-1H-indole-1-carboxylate (12). 24.0 g (93.7 mmol) of 11 was dissolved in THF (200 mL), followed by 30.76 g (1.5 equiv.) of di-tert-S36 butyl dicarbonate with an additional 50 mL of THF to wash down the sides of the flask. 0.59 g (0.052 equiv.) of DMAP was then added and the reaction was heated to 40°C for two hours. At that time, TLC showed that all of the starting material had been consumed, so 250 mL of DCM was added to the reaction and the organic solution was washed with water (2 x 100 mL), dried over sodium sulfate and evaporated in vacuo to give a viscous brown oil. The product was purified via normal phase flash chromatography (EPCLC W-Prep 2XY, Yamazen Corp.) using an increasing gradient of ethyl acetate/hexanes (10:90 to 100:0 over 100 minutes). The fractions containing the desired product were combined and evaporated in vacuo to give 17.27 g (51.7% yield) of 12 as a white solid. 1 H NMR (300 MHz, DMSO) δ 9.57 (t, J = 5.78 Hz, 1H), 8.05 (d, J = 8.20 Hz, 1H), 7.62 (d, J = 7.48 Hz, 1H), 7.50 (s, 1H), 7.33 (td, J = 1.39, 7.77, 8.28 Hz, 1H), 7.25 (td, J = 1.17, 7.44 Hz, 1H) , 3.49 (q, J = 6.72 Hz, 2H), 2.91 (t, J = 6.98 Hz, 2H), 1.61 (s, 9H). 13 C NMR (75 MHz, DMSO) δ 156. 51, 156.03, 149.02, 134.78, 130.13, 124.42, 123.18, 122.52, 119.07, 117.40, 114.74, 83.48, 39.07, 27.67, 23.53 . "NTrp"). 17.20 g (48.27 mmol) of 12 was dissolved in methanol (60 mL) followed by the addition of 16.75 g (2.511 equiv.) of potassium carbonate dissolved in water (60 mL). The reaction flask was covered and the reaction was allowed to stir overnight at room temperature. After 16 hours of reaction time, little progress was seen with the reaction, so it was heated to reflux for seven hours. At that time, TLC showed that all starting material had been consumed. Methanol was evaporated in vacuo, and the remaining aqueous solution was adjusted to pH >10 with 4 N NaOH. The product was extracted with DCM (3 x 200 mL), and the combined organics were washed with water (100 mL) and brine (100 mL), dried over sodium sulfate, filtered and evaporated in vacuo to give 7.05 g (56.1% yield) of 13 as a S37 yellow oil. 1 H NMR (300 MHz, CDCl3) δ 7. 60 -7.46 (m, 1H), 7.46 -7.36 (m, 1H), 7.34 -7.17 (m, 3H), 3.54 (t, J = 7.74 Hz, 2H), 3.03 (t, J = 7.11 Hz, 2H), 1.66 (s, 9H), 1.64 (s, 2H, NH2). 13 C NMR (75 MHz, CDCl3) δ 167.81, 135.55, 130.74, 124.17, 123.05, 122.72, 122.26, 118.98, 115.15, 83.27, 51.28, 28.17, 26.50. HRMS (ESI) Synthesis of (4-(tert-butoxy)phenyl)methanamine (14; "NTyr") . 175 mL of 1M (175 mmol; 2.6 eq.) lithium aluminum hydride in THF was added to a round bottom flask with a stir bar and was cooled to 0°C. A solution of 11.83 g (67.5 mmol) of 4-(tert-butoxy)benzonitrile (Alfa Aesar, Ward Hill, MA) in 50 mL of anhydrous THF was added to the stirring solution dropwise over the course of 30 minutes. The reaction was then fitted with a reflux condenser and was heated to reflux for six hours, followed by stirring overnight under argon, allowing the reaction to cool to room temperature. After 22 hours of total reaction time, the reaction mixture was cooled to 0°C and was quenched with 7 mL of water, followed by 6 mL of 15% NaOH (aq) and an additional 17 mL of water. The resulting emulsion was filtered over celite, with the filter cake being washed with methanol (2 x 50 mL) and DCM (2 x 50 mL). The filtrate was evaporated, and the resulting dark yellow oil was dissolved into 75 mL of water. The solution was transferred to a separatory funnel and was extracted with ethyl acetate (4 x 150 mL). The combined extractions were washed with water (100 mL) and brine (100 mL), dried over sodium sulfate, and evaporated in vacuo to give a dark yellow oil. The oil was separated using basic alumina chromatography and a solvent system of ethyl acetate/hexanes (20:80 to 50:50). The fractions containing the product (as evidenced by S38 TLC) were combined and evaporated to give 5.71 g (47.2% yield) of 14 as a clear oil. 1 H NMR (300 MHz, CDCl3) δ 7.19 (dd, J = 2.26, 6.46 Hz, 2H), 6.94 (dd, J = 2.32, 6.46 Hz, 2H), 4.38 (s, 2H), 1.31 (s, 9H). 13 C NMR (75 MHz, CDCl3) δ 153. 80, 135.32, 128.26, 124.27, 78.17, 54.93, 28.75 Synthesis of (S)-4-(4-(2-amino-3-hydroxypropyl)-2,6-diiodophenoxy)phenol (15; "T2AA"). 7.55 mL of 1 M (15.1 mmol) lithium borohydride in THF was added to a 50 mL round bottom flask followed by 5.2 mL of anhydrous THF and 5 mL of anhydrous dioxane. The solution was cooled to 0°C under argon, and 3.85 mL (30.3 mmol) of chlorotrimethylsilane was slowly added. The resulting solution was stirred for 15 minutes at 0°C, and 0.90 g (1.71 mmol) of 3,5-diiodo-Lthyronine (Combi-Blocks, Inc.) was added in one portion with the aid of an additional 5.2 mL of anhydrous THF and 5 mL of anhydrous dioxane. The flask was sealed and the reaction was stirred overnight under argon while being allowed to slowly warm to room temperature. After 18 hours of reaction time, the reaction was poured into 25 mL of ice-water, adjusted to pH >9 with 4 N NaOH and was extracted with ethyl acetate (3 x 50 mL). The combined organic extractions were dried over sodium sulfate, filtered and evaporated to give a light brown solid. This solid was dissolved in a mixture of ACN/H2O (75:25) and was purified on an Agilent ZORBAX SB-C18 reverse phase semi-preparative column on a System Gold 166 (Beckman Coulter) HPLC system, S39 using a gradient of ACN (0.1% TFA)/H2O (0.1% TFA) 0:100 to 100:0 over 30 minutes with detection at 254 nm. The fractions containing the purified product were combined, frozen and lyophilized to give 460 mg (52.5% yield) of 15 as a fluffy white solid. 1 H NMR (300 MHz, DMSO) δ 9.12 (s, 1H), 7.84 (s, 5H), 6.68 (dt, J = 2.30, 3.84, 9.08 Hz, 2H), 6.54 (dt, J = 2.30, 3.61, 8.98 Hz, 2H), 5.39 (t, J = 4.49 Hz, 1H), 3.56 (dd, J = 4.86, 7.97 Hz, 1H), 3.40 (dq, J = 5.48, 9.94 Hz, 2H), 2.87 -2.69 (m, 2H), 2.07 (s, 1H). 13 C NMR (126 MHz, DMSO) δ 152. 65, 152.26, 148.83, 140.67, 137.48, 115.86, 115.82, 92.48, 60.07, 53.27, 40.02, 39.85, 39.78, 39.69, 39.52, 39.35, 39.19, 39.02, 33. containing an N-terminal His-tag and TEV protease recognition site was linearized by digestion with Ssp1 (New England Biolabs), purified by gel filtration, and treated with T4 DNA polymerase (Novagen) in the presence of dGTP (New England Biolabs) for 30 minutes at 22°C, followed by heat inactivation at 75°C for 20 minutes. The PCNA fragment was amplified by PCR from a template plasmid (Genecopeia) using a high-fidelity polymerase Platinum Pfx DNA polymerase (Invitrogen). The resulting PCR products were treated with T4 DNA polymerase in the presence of dCTP to generate 5' overhangs necessary for annealing. A total of 0.2 pmol of each insert was incubated with 0.01 pmol of pEV-L8 vector in 3 µL reaction mix at 22°C for 10 minutes followed by addition of 1 µL of 25 mM EDTA at 22°C for 5 minutes. Annealing reaction products were transformed into X10Gold competent cells (Strategene) and plated on LB agar containing 50 µg/mL kanamycin. Individual colonies were grown and the constructs were assessed by PCR for insert size and verified by sequencing before propagating the plasmid. E. Coli cells (Agilent) were transformed via heat shock with 1 µL of purified plasmid encoding the fusion protein, N-terminal (His)6-PCNA for 30 seconds at 42°C. The cells were then immediately placed on ice for 2 minutes, and 140 µL of SOC medium was added. Transformed cells were allowed to grow for 1 hour at 37°C before streaking on a LB agar plate containing 50 µg/mL kanamycin. Single isolated colonies were picked and grown at 37°C to an OD of 0.7-1.0 in the presence of 50 µg/mL kanamycin. Transformed cells were induced with 0.4 mM IPTG for 4 hours at 37°C. Transformed cells were pelleted at 4,000 x g for 20 minutes at 4°C, and stored at -80°C until lysis.
Synthesis of tert
Synthesis of tert-butyl 3-(2-aminoethyl)-1H
Two pellets of transformed BL21 (DE3) E. Coli cells were each resuspended in 20 ml of ice-cold lysis buffer (50 mM Tris HCl at pH 8.0, 0.15 mM NaCl), lysed by sonication at a 30% amp output for 3 minutes (20 second pulses), and centrifuged at 4,000 x g for 20 minutes at 4°C.
Each supernatant was decanted and combined. Recombinant (His)6-PCNA fusion protein was then purified from the soluble fraction by affinity column chromatography using Ni-NTA resin at 4°C.
After charging the column resin with the entire soluble protein fraction, the column was washed with 20 mM imidazole in Tris buffer at pH 8.0 to remove nonspecific binding protein. (His)6-PCNA was then eluted with 10 mL of 1M imidazole in Tris buffer at pH 8.0. The eluted protein was diluted two-fold with dialysis buffer (25 mM HEPES at pH 7.4, 10% glycerol, 0.01% Triton X-100), DTT and EDTA were added to a final concentration of 2 mM, and the entire solution was diluted two-fold with 2 M ammonium sulfate in 25 mM Tris buffer at pH 8.0 to give a final (NH4)2SO4 concentration of 1 M. The solution was agitated for 1 hour at 4°C, and during that time
